» Articles » PMID: 16810510

Commercial Living Non-related Organ Transplantation: a Viewpoint from a Developed Country

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2006 Jul 1
PMID 16810510
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In developed countries, the use of living unrelated donors is restricted to purely altruistic donors who have a close and emotional relationship with the recipients. By law, commercial transplantation is illegal. Increasing shortness of donors, the excellent results of kidney transplants from spousal and living unrelated donors as well as the very low risk for the donor has been used as an argument for paid organ donation. Arguments in favour are the relief of donor-organ shortage, short waiting times for renal transplantation, economic benefits for the donor as well as the economic benefits for society by reducing the costs of dialysis by more transplants. Major arguments against are exploitation of the donor, coercion, and a growing black market. Despite the fact that different societies have different norms or reproaches that we are failing our patients and accept the death of thousands, kidney trade has created an environment of corruption and commercialisation, which brings even the cadaver transplant program into disrepute. However, denying the existence of paid organ donation does not contribute to solve the problem. A public discussion about consequences of changing ethics and human rights, rather than pragmatic solutions, is needed.

Citing Articles

Risk Assessment and Management for Potential Living Kidney Donors: The Role of "Third-Party" Commission.

Tattoli L, Santovito D, Raciti I, Scarmozzino A, Di Vella G Front Public Health. 2022; 10:824048.

PMID: 35372186 PMC: 8968079. DOI: 10.3389/fpubh.2022.824048.


Commercial Kidney Transplantation: Attitude, Knowledge, Perception, and Experience of Recipients.

Al Rahbi F, Al Salmi I Kidney Int Rep. 2017; 2(4):626-633.

PMID: 29142981 PMC: 5678620. DOI: 10.1016/j.ekir.2017.02.010.


Commercial renal transplantation: A risky venture? A single Canadian centre experience.

Kapoor A, Kwan K, Whelan J Can Urol Assoc J. 2011; 5(5):335-40.

PMID: 22031615 PMC: 3202007. DOI: 10.5489/cuaj.11018.


Related and unrelated living donor transplantation.

Mehls O, Baum M Pediatr Nephrol. 2006; 21(10):1351.

PMID: 16823573 DOI: 10.1007/s00467-006-0186-3.

References
1.
Kranenburg L, Visak T, Weimar W, Zuidema W, de Klerk M, Hilhorst M . Starting a crossover kidney transplantation program in the Netherlands: ethical and psychological considerations. Transplantation. 2004; 78(2):194-7. DOI: 10.1097/01.tp.0000129259.02340.f7. View

2.
Kevorkian J . Marketing of human organs and tissues is justified and necessary. Med Law. 1989; 7(6):557-65. View

3.
Mansy H, Khalil A, Aly T, Filobbos P, Al-Dusari S, Al-Shareef Z . Outcome of commercial renal transplantation: two years follow-up. Nephron. 1996; 74(3):613-6. DOI: 10.1159/000189462. View

4.
Naqvi A, Rizvi A . Against paid organ donation. Transplant Proc. 2001; 33(5):2628. DOI: 10.1016/s0041-1345(01)02119-4. View

5.
Reddy K . Should paid organ donation be banned in India? To buy or let die!. Natl Med J India. 1993; 6(3):137-9. View